Երկիր: Ավստրալիա
Լեզու: անգլերեն
Աղբյուրը: Department of Health (Therapeutic Goods Administration)
clozapine, Quantity: 25 mg
Viatris Pty Ltd
Tablet, uncoated
Excipient Ingredients: lactose monohydrate; maize starch; colloidal anhydrous silica; povidone; magnesium stearate; purified talc
Oral
28 tablets, 100 x 25 mg tablets, 50 x 25mg tablet
(S4) Prescription Only Medicine
CLOZAPINE MYLAN is indicated in treatment-resistant schizophrenic patients only, ie. schizophrenic patients who are non-responsive to, or intolerant of other antipsychotic drugs. Non-responsiveness is defined as a lack of satisfactory clinical improvement despite the use of adequate doses of at least two classes of marketed antipsychotic drugs prescribed for reasonable durations. Intolerance is defined as the impossibility to achieve adequate benefit with other antipsychotic drugs because of severe and untreatable neurological adverse reactions (extrapyramidal side effects or tardive dyskinesia).
Visual Identification: Yellow flat circular tablet with bevelled edge, 6.3 mm in diameter, angle scored, marked "LO" on one side and "SANDOZ" on the other.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 5 Years; Container Temperature: Store below 30 degrees Celsius
Registered
2020-01-10